LITTLE KNOWN FACTS ABOUT ECSTASYS SHOP.

But The trail towards acceptance has long been bumpy, with advisers towards the F.D.A. noting many shortcomings in Lykos’s software As well as in gaps in the information the corporation had submitted. The panel, which voted 10 to 1 in opposition to the application, cited numerous issues, including Lykos’s failure to gather in-depth information